Article
DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in…
OncoTargets and Therapy · 2019 · Yue C, Liang C, Li P, Yan L, Zhang D, Xu Y, Wei Z, Wu J
Key facts
| Title | DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation |
|---|---|
| First author | Yue C, Liang C, Li P, Yan L, Zhang D, Xu Y, Wei Z, Wu J |
| Journal | OncoTargets and Therapy |
| Published | Dec 31, 2019 |
| DOI | 10.2147/OTT.S231750 |
| Devices mentioned | 201806, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1